EP1001816A4 - Perfluorinated-ether compositions as diagnostic contrast agents - Google Patents

Perfluorinated-ether compositions as diagnostic contrast agents

Info

Publication number
EP1001816A4
EP1001816A4 EP97946447A EP97946447A EP1001816A4 EP 1001816 A4 EP1001816 A4 EP 1001816A4 EP 97946447 A EP97946447 A EP 97946447A EP 97946447 A EP97946447 A EP 97946447A EP 1001816 A4 EP1001816 A4 EP 1001816A4
Authority
EP
European Patent Office
Prior art keywords
perfluorinated
contrast agents
ether compositions
diagnostic contrast
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97946447A
Other languages
German (de)
French (fr)
Other versions
EP1001816A1 (en
Inventor
Evan C Unger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ImaRx Pharmaceutical Corp
Original Assignee
ImaRx Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ImaRx Pharmaceutical Corp filed Critical ImaRx Pharmaceutical Corp
Publication of EP1001816A1 publication Critical patent/EP1001816A1/en
Publication of EP1001816A4 publication Critical patent/EP1001816A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
EP97946447A 1996-11-25 1997-11-03 Perfluorinated-ether compositions as diagnostic contrast agents Withdrawn EP1001816A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3190396P 1996-11-25 1996-11-25
US31903P 1996-11-25
US80099397A 1997-02-20 1997-02-20
US800993 1997-02-20
PCT/US1997/019900 WO1998023298A1 (en) 1996-11-25 1997-11-03 Perfluorinated-ether compositions as diagnostic contrast agents

Publications (2)

Publication Number Publication Date
EP1001816A1 EP1001816A1 (en) 2000-05-24
EP1001816A4 true EP1001816A4 (en) 2002-07-17

Family

ID=26707753

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97946447A Withdrawn EP1001816A4 (en) 1996-11-25 1997-11-03 Perfluorinated-ether compositions as diagnostic contrast agents

Country Status (3)

Country Link
EP (1) EP1001816A4 (en)
AU (1) AU5161298A (en)
WO (1) WO1998023298A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0811856D0 (en) 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
RU2541175C2 (en) 2009-06-30 2015-02-10 Конинклейке Филипс Электроникс Н.В. Quantitative analysis of perfusion

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350571A (en) * 1988-04-29 1994-09-27 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
WO1995031965A1 (en) * 1994-05-20 1995-11-30 Minnesota Mining And Manufacturing Company Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
WO1996031196A1 (en) * 1995-04-05 1996-10-10 Imarx Pharmaceutical Corp. Novel compositions of lipids and stabilizing materials
WO1996040281A2 (en) * 1995-06-07 1996-12-19 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low ostwald coefficients
WO1998004292A2 (en) * 1996-07-29 1998-02-05 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
WO1998042384A1 (en) * 1997-03-21 1998-10-01 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4004430A1 (en) * 1990-02-09 1991-08-14 Schering Ag CONSTRUCTED POLYALDEHYDE CONSTITUENTS
JP3746293B2 (en) * 1993-02-22 2006-02-15 アメリカン バイオサイエンス、インコーポレイテッド Methods for in vivo delivery of biologics and compositions therefor

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350571A (en) * 1988-04-29 1994-09-27 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
WO1995031965A1 (en) * 1994-05-20 1995-11-30 Minnesota Mining And Manufacturing Company Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
WO1996031196A1 (en) * 1995-04-05 1996-10-10 Imarx Pharmaceutical Corp. Novel compositions of lipids and stabilizing materials
WO1996040281A2 (en) * 1995-06-07 1996-12-19 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low ostwald coefficients
WO1998004292A2 (en) * 1996-07-29 1998-02-05 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
WO1998042384A1 (en) * 1997-03-21 1998-10-01 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9823298A1 *

Also Published As

Publication number Publication date
AU5161298A (en) 1998-06-22
EP1001816A1 (en) 2000-05-24
WO1998023298A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
IL129423A0 (en) Improved preparation for use as contrast agent
GB9600426D0 (en) Compositions
ZA957233B (en) Topically-effective compositions
EG20929A (en) Cleasing compositions
PL332118A1 (en) Remineralisable compositions
GB9408545D0 (en) Compositions
IL128718A0 (en) Naaldase compositions
IL130330A0 (en) Endo-ectoparasiticidal compositions
GB9624540D0 (en) Compositions
GB9409543D0 (en) Compositions
GB9623562D0 (en) Sachet-packaged compositions
GB9620504D0 (en) Compositions
GB9502770D0 (en) Amine-curable compositions
HRP970569B1 (en) Fharmaceutical compositions
HUP0002204A3 (en) Diagnostic composition
GB9606715D0 (en) Rinsing compositions
ZA954709B (en) Mineral-fiber compositions
GB2290299B (en) Anti-lubricant compositions
GB2308812B (en) Antiseptic compositions
GB9416768D0 (en) Compositions
EP0705632A3 (en) 2-Methylpropenyl-terminated polyisobutylene-polydimethyl-siloxane compositions
EP1001816A4 (en) Perfluorinated-ether compositions as diagnostic contrast agents
GB9611365D0 (en) Compositions
GB9620503D0 (en) Compositions
GB9416767D0 (en) Compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990618

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 49/04 A, 7C 07C 41/00 B, 7C 07C 19/08 B, 7A 61K 47/48 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020528

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB IT

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20030321

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1027295

Country of ref document: HK